Total Funding
62
55
Total FundingVenture - Series Unknown raised
Growth Score
-9 pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
95270
jCyte is a developer of cell-based technology intended to cure retinitis pigmentosa.
- Henry J. Klassen: Co-Founder
- Jing Yang: Co-Founder & Chief Scientific Officer
About the Company
jCyte is a developer of cell-based technology intended to cure retinitis pigmentosa. The company's therapy used retinal progenitor cells can secrete growth factors to rescue damaged retinal cells which help in treating a degenerative eye disease that ultimately causes blindness enabling, patients afflicted by conditions that lead to blindness,
preserve and restore sight. They focused on the application of progenitor cell-based technology in retinal diseases.
Women Founded
